These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28974844)

  • 21. Aliskiren - a promising strategy for ovarian ischemia/reperfusion injury protection in rats via RAAS.
    Bayir Y; Cadirci E; Polat B; Kilic Baygutalp N; Albayrak A; Karakus E; Un H; Keles MS; Kocak Ozgeris FB; Toktay E; Karaca M; Halici Z
    Gynecol Endocrinol; 2016 Aug; 32(8):675-683. PubMed ID: 26939623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive and anti-inflammatory actions of combined azilsartan and chlorthalidone in Dahl salt-sensitive rats on a high-fat, high-salt diet.
    Jin C; O'Boyle S; Kleven DT; Pollock JS; Pollock DM; White JJ
    Clin Exp Pharmacol Physiol; 2014 Aug; 41(8):579-88. PubMed ID: 24798707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The renin inhibitor aliskiren protects rat lungs from the histopathologic effects of fat embolism.
    Fletcher AN; Molteni A; Ponnapureddy R; Patel C; Pluym M; Poisner AM
    J Trauma Acute Care Surg; 2017 Feb; 82(2):338-344. PubMed ID: 28107310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trigonelline attenuates hepatic complications and molecular alterations in high-fat high-fructose diet-induced insulin resistance in rats.
    Afifi NA; Ramadan A; Erian EY; Saleh DO; Sedik AA; Badawi M; El Hotaby W
    Can J Physiol Pharmacol; 2017 Apr; 95(4):427-436. PubMed ID: 28157387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats.
    Wang Y; Li JY; Han M; Wang WL; Li YZ
    Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
    Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
    Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of renin-angiotensin-aldosterone system blockade on chlorhexidine gluconate-induced sclerosing encapsulated peritonitis in rats.
    Koçak G; Azak A; Astarcı HM; Huddam B; Karaca G; Ceri M; Can M; Sert M; Duranay M
    Ther Apher Dial; 2012 Feb; 16(1):75-80. PubMed ID: 22248199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
    van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
    J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
    Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
    Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
    World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
    Tan DY; Shi HY; Li CP; Zhong XL; Kang M
    World J Gastroenterol; 2015 May; 21(19):5877-83. PubMed ID: 26019451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
    Kusumoto K; Igata H; Ojima M; Tsuboi A; Imanishi M; Yamaguchi F; Sakamoto H; Kuroita T; Kawaguchi N; Nishigaki N; Nagaya H
    Eur J Pharmacol; 2011 Nov; 669(1-3):84-93. PubMed ID: 21816148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
    Duan X; Meng Q; Wang C; Liu Z; Sun H; Huo X; Sun P; Ma X; Peng J; Liu K
    J Gastroenterol Hepatol; 2018 Feb; 33(2):533-542. PubMed ID: 28699662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of aliskiren and valsartan in mice with diabetic nephropathy.
    Wang W; Qiu L; Howard A; Solis N; Li C; Wang X; Kopp JB; Levi M
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):384-95. PubMed ID: 25031296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice.
    Higashikuni Y; Takaoka M; Iwata H; Tanaka K; Hirata Y; Nagai R; Sata M
    Hypertens Res; 2012 Jan; 35(1):62-9. PubMed ID: 21833001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aliskiren attenuates chronic carbon tetrachloride-induced liver injury in mice.
    Lee KC; Chan CC; Yang YY; Hsieh YC; Huang YH; Lin HC
    Eur J Clin Invest; 2012 Dec; 42(12):1261-71. PubMed ID: 22998019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telmisartan and candesartan promote browning of white adipose tissue and reverse fatty liver changes in high fat diet fed male albino rats.
    Abbas NAT; Fayed FA; El Sebaey RS; Hassan HA
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2359-2378. PubMed ID: 37831115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice.
    Sun H; Wang X; Chen J; Song K; Gusdon AM; Li L; Bu L; Qu S
    Lipids Health Dis; 2016 Nov; 15(1):202. PubMed ID: 27876064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
    Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
    Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats.
    Zhao M; Li Y; Wang J; Ebihara K; Rong X; Hosoda K; Tomita T; Nakao K
    Diabetes Obes Metab; 2011 Dec; 13(12):1123-9. PubMed ID: 21749604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.